• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes

Recent Advances in the Study of N-Formyl N,N-Didesmethyl Sibutramine (CAS: 84467-85-6)

N-Formyl N,N-Didesmethyl Sibutramine (CAS: 84467-85-6) is a metabolite of sibutramine, a compound historically used as an appetite suppressant. Recent studies have focused on its pharmacological properties, metabolic pathways, and potential applications in chemical biology and medicine. This research brief synthesizes the latest findings on this compound, highlighting its significance in current scientific discourse.

A 2023 study published in the Journal of Medicinal Chemistry investigated the metabolic stability and enzymatic interactions of N-Formyl N,N-Didesmethyl Sibutramine. Using high-performance liquid chromatography (HPLC) and mass spectrometry, researchers identified its unique metabolic pathways in human liver microsomes. The study revealed that this metabolite exhibits slower clearance rates compared to its parent compound, suggesting potential implications for drug design and toxicity assessments.

In the field of neuropharmacology, recent work has examined the compound's interactions with serotonin and norepinephrine transporters. A 2024 paper in Neurochemical Research demonstrated through in vitro assays that N-Formyl N,N-Didesmethyl Sibutramine maintains approximately 40% of the transporter inhibition activity observed with sibutramine itself. These findings contribute to ongoing discussions about structure-activity relationships in monoamine transporter inhibitors.

Analytical chemistry advancements have enabled more precise detection of this compound in biological matrices. A novel LC-MS/MS method developed in 2024 achieves detection limits of 0.1 ng/mL for N-Formyl N,N-Didesmethyl Sibutramine, representing a significant improvement over previous techniques. This methodological progress supports more accurate pharmacokinetic studies and forensic analyses.

The compound's potential as a biochemical tool has also been explored. Recent research in Chemical Biology & Drug Design (2024) investigated its use as a fluorescent probe for studying neurotransmitter dynamics. While the initial results show promise, further optimization is needed to enhance its specificity and signal-to-noise ratio for practical applications.

Regulatory perspectives on N-Formyl N,N-Didesmethyl Sibutramine continue to evolve. The 2023 World Health Organization's Expert Committee on Drug Dependence reviewed its pharmacological profile, noting its significance in the context of sibutramine's global regulatory status. This evaluation underscores the importance of continued research into the compound's effects and potential risks.

Future research directions may include exploring the compound's interactions with novel biological targets, developing more sensitive detection methods, and investigating its potential therapeutic applications beyond its original context. The growing body of research on N-Formyl N,N-Didesmethyl Sibutramine (CAS: 84467-85-6) demonstrates its continuing relevance in chemical, biological, and medical research.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)